Ways2Well review

What it is

Ways2Well is a lab-based telehealth and longevity membership founded by Brigham Buhler, built around comprehensive blood panels and biomarker tracking, with its own patient app. Beyond peptides it covers hormone optimisation, compounded GLP-1 therapy for weight loss, stem-cell and regenerative services, and IV therapy. Its compounded prescriptions are filled by ReviveRX, a named sister compounding pharmacy — an ownership relationship rather than a supplier one, which is rare disclosure. A separate storefront sells oral supplements and lab panels.

How it works

A membership with labs at the front, which is a meaningfully different starting point from a five-question quiz. The proposition is that a comprehensive panel establishes baseline biomarkers, a clinician builds a protocol against them, and follow-up testing tracks the response — for growth-hormone secretagogues in particular, that is the right sequence, since IGF-1 is the measurable variable and prescribing without it is guesswork. Owning the dispensing pharmacy is the second structural argument: it removes a markup layer and puts accountability for the preparation inside the same company that wrote the prescription. Both are genuine. The practical problem is that none of it is inspectable from outside. The site is a client-side application that returns the same empty shell for every route, including every product page, so a prospective patient using a screen reader, a slow connection or any tool that does not execute scripts sees nothing at all — and neither could we. Its storefront, which does render, sells only oral supplements and lab panels, which is why a casual look suggests there is no peptide business when there plainly is. State coverage is described as limited and expanding, with a state selector rather than a published list.

Pricing transparency

Unverifiable, and that is the honest answer rather than a placeholder for one. No price for sermorelin, CJC-1295/ipamorelin, tesamorelin, BPC-157 or GHK-Cu could be read from any product page, because no product page renders. Nor could we confirm whether peptides are sold standalone or only inside the membership, what the membership itself costs, or whether the paid peptide consultation the sitemap lists is a separate charge. Third-party directories circulate a figure for its GLP-1 line that we could not confirm on the company's own site, so we repeat none of it — an unverified number from a directory is not a price, and substituting a GLP-1 figure for a peptide figure would be wrong twice over. We publish no floor. If you pursue this, the questions to ask before booking are: the cost of the initial panel, the membership fee, the monthly cost of the specific peptide you want, and whether the peptide price is standalone or membership-gated. The lab-first model means your first bill is likely testing, not medication.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are, though a company-owned pharmacy at least means the preparation and the prescription sit under one accountable entity rather than two. On the evidence, the peptide list its sitemap enumerates spans the full range and a reader should not treat catalog membership as endorsement. Sermorelin, CJC-1295 with ipamorelin, and tesamorelin all act on the growth-hormone axis: real, well-described mechanisms with thin long-term human outcome data, and tesamorelin's approval is narrow — HIV-associated lipodystrophy specifically — so other uses are off-label. BPC-157 has no controlled human outcome trials at all; its tendon, gut and tissue-repair reputation rests on rodent work, and it is among the compounds the FDA has placed in a restricted category. GHK-Cu likewise has essentially no controlled human outcome data behind its collagen and skin claims. Bloodwork improves the prescribing decision; it does not upgrade the evidence for the molecule. Individual results vary.

Pros and watch-outs

The evidence behind what Ways2Well prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• Ipamorelin & CJC-1295: the honest evidence on GH secretagogue peptides

  They reliably raise growth hormone — that part is real. The muscle, fat-loss and anti-aging claims are not supported by human outcome data. A straight read.

• Tesamorelin (Egrifta): what it's actually FDA-approved for, and the evidence

  A real, approved GHRH analog — for HIV-associated lipodystrophy specifically. What the pivotal trials showed, and why the longevity use is an extrapolation.

• BPC 157: what the evidence actually shows (and what it doesn't)

  The 'healing peptide' has a deep rodent literature and almost no human data. A straight read of where the science stands.

• GHK-Cu: the copper peptide between real skincare and overclaim

  A decades-deep molecule with a credible topical story — and systemic anti-aging claims that outrun the human data.

How Ways2Well compares

A few alternatives worth a look, depending on what you’re optimizing for.

• VWVyora Wellness

  NAD⁺ at one flat published monthly price with no membership and no dose-escalation surcharge

  See Vyora Wellness →
• WEWePeptideRx

  NAD⁺ buyers who want milligrams, cadence and supply length stated before they compare a price

  See WePeptideRx →
• VBVita Bella

  People who want peptides inside a supervised membership and will do the two-part arithmetic first

  See Vita Bella →